1. Home
  2. VTVT vs CAAS Comparison

VTVT vs CAAS Comparison

Compare VTVT & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$35.77

Market Cap

143.7M

Sector

Health Care

ML Signal

HOLD

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.16

Market Cap

130.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTVT
CAAS
Founded
2015
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
143.7M
130.6M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VTVT
CAAS
Price
$35.77
$4.16
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$55.25
N/A
AVG Volume (30 Days)
27.0K
27.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,017,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.97
Revenue Growth
N/A
N/A
52 Week Low
$14.00
$3.50
52 Week High
$44.00
$5.37

Technical Indicators

Market Signals
Indicator
VTVT
CAAS
Relative Strength Index (RSI) 48.13 35.21
Support Level $31.42 $4.13
Resistance Level $42.71 $4.40
Average True Range (ATR) 3.35 0.14
MACD -0.11 -0.04
Stochastic Oscillator 19.78 6.00

Price Performance

Historical Comparison
VTVT
CAAS

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: